| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/04/2013 | CN103417574A Preparation method of recombinant antimicrobial peptide extracted from small intestine of pig and application thereof |
| 12/04/2013 | CN103417548A Health-care method for breeding period in pig raising process |
| 12/04/2013 | CN103416598A Preparation method of micro-encapsulation coated yolk derived cholecystokinin antibodies |
| 12/04/2013 | CN102747048B Mycobacterium tuberculosis candidate antigen and its application |
| 12/04/2013 | CN102675425B Functional mycobacterium tuberculosis antigen polypeptide and application thereof |
| 12/04/2013 | CN102653554B Functional mycobacterium tuberculosis antigen polypeptide and application thereof |
| 12/04/2013 | CN102614504B Pseudomonas fluorescens recombinant protein vaccine and preparation method thereof |
| 12/04/2013 | CN102558351B Anti to human alkaline fibroblast growth factor human s c F v antibody and application thereof |
| 12/04/2013 | CN102335424B II type adenovirus live vector recombinant vaccine of dog for showing lyssa virus protective antigen by using IX protein |
| 12/04/2013 | CN102169121B New application of human kinase SBK1 (SH3-binding domain kinase 1) |
| 12/04/2013 | CN102139101B Application of protein Com1 in immunoprotection of coxiella burnetii |
| 12/04/2013 | CN102134275B 表皮生长因子受体变异体 Epidermal growth factor receptor variant |
| 12/04/2013 | CN102038950B Novel immune adjuvant and vaccine containing same |
| 12/04/2013 | CN102028944B Combination vaccines with low dose of HIB conjugate |
| 12/04/2013 | CN101926993B Adjuvant systems and vaccines |
| 12/04/2013 | CN101897966B Cynomorium songaricum immunological adjuvant and influenza vaccine comprising same |
| 12/04/2013 | CN101500606B A direct drug delivery system based on thermally responsive biopolymers |
| 12/04/2013 | CN101489585B Method of immunisation against the four serotypes of dengue |
| 12/04/2013 | CN101448848B Ras mutation and compositions and methods related thereto |
| 12/04/2013 | CN101287841B Anti-alpha(v)beta(6) antibodies and uses thereof |
| 12/04/2013 | CN101137673B Cripto结合分子 Cripto binding molecules |
| 12/03/2013 | US8598324 Anti-pathogen treatments |
| 12/03/2013 | US8598322 Anti CEACAM1 antibodies and methods of using same |
| 12/03/2013 | US8598321 Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins |
| 12/03/2013 | US8598137 Use of SAM68 for modulating signaling through the TNF receptor |
| 12/03/2013 | US8597898 Fusion polypeptides capable of activating receptors |
| 12/03/2013 | US8597665 Chimeric immunomodulatory compounds and methods of using the same-IV |
| 12/03/2013 | US8597664 Endogenous adjuvant molecules and uses thereof |
| 12/03/2013 | US8597663 Polysaccharide immunogens from Clostridium difficile |
| 12/03/2013 | US8597662 Vaccine for protection against Lawsonia intracellularis |
| 12/03/2013 | US8597661 Neuraminidase-deficient live influenza vaccines |
| 12/03/2013 | US8597660 Therapeutic approach to neurodegenerative disorders using a TFP5-peptide |
| 12/03/2013 | US8597659 Tetrameric cytokines with improved biological activity |
| 12/03/2013 | US8597658 HIV-1 envelope glycoprotein oligomer and methods of use |
| 12/03/2013 | US8597657 Mutated env sequence involved in the modulation of the immunosuppressive effect of viral proteins |
| 12/03/2013 | US8597656 Process for the production of immunogenic compositions |
| 12/03/2013 | US8597655 Recombinant fusion protein and polynucleotide construct for immunotoxin production |
| 12/03/2013 | US8597654 Adjuvant therapy with an anti-ERBB2 antibody conjugated to a maytansiniod |
| 12/03/2013 | US8597652 Multispecific anti-HER antibodies |
| 12/03/2013 | US8597651 Monomeric VHH domain derived from anti-VP6 camelid antibodies, dimeric domain, immunisation method, rotavirus detection method, composition, prevention and treatment methods for rotavirus infections |
| 12/03/2013 | US8597650 Methods for treating rheumatoid arthritis with anti-bile salt-stimulated lipase (BSSL) antibodies |
| 12/03/2013 | US8597649 Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| 12/03/2013 | US8597648 Fully human anti-TNF-alpha monoclonal antibody, preparation method and use thereof |
| 12/03/2013 | US8597647 Humanized anti-IL-20 antibody and uses thereof |
| 12/03/2013 | US8597646 Methods and compositons featuring TGF-beta antagonists for the treatment of marfan syndrome and associated disorders |
| 12/03/2013 | US8597645 Cancer treatment with endothelin receptor antagonists |
| 12/03/2013 | US8597644 Method for treating psoriasis by administering an antibody to interleukin-6 receptor |
| 12/03/2013 | US8597643 Antibodies for binding to non-functional P2X7 receptors in trimeric form |
| 12/03/2013 | US8597636 Method for treating autoimmune diseases and compositions therefor |
| 12/03/2013 | US8597635 Interferon alpha-2B modified by polyethylene glycol and methods of preparation thereof |
| 12/03/2013 | US8597634 Interferon alpha-2a modified by polyethylene glycol and methods of preparation thereof |
| 12/03/2013 | CA2699366C Peptide-lipid constructs and their use in diagnostic and therapeutic applications |
| 12/03/2013 | CA2583499C Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof |
| 12/03/2013 | CA2555714C Methods for preparing t-cells for cell therapy |
| 12/03/2013 | CA2539457C Nucleic acid and gene derived from novel hcv strain and replicon-replicating cell using said gene |
| 12/03/2013 | CA2519227C Nogo receptor binding protein |
| 12/03/2013 | CA2499837C Human papillomavirus polypeptides and immunogenic compositions |
| 12/03/2013 | CA2474497C Compositions and methods related to tim-3, a th1-specific cell surface molecule |
| 12/03/2013 | CA2463017C Method for preparation of single chain antibodies |
| 12/03/2013 | CA2397207C Novel stra6 polypeptides |
| 12/03/2013 | CA2240834C Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines |
| 12/03/2013 | CA2213610C Ingap protein involved in pancreatic islet neogenesis |
| 11/28/2013 | WO2013177596A2 Methods for treating gi syndrome and graft versus host disease |
| 11/28/2013 | WO2013177444A2 Influenza vaccine constructs |
| 11/28/2013 | WO2013177440A2 Ordered flagellin array as an immunostimulant |
| 11/28/2013 | WO2013177428A1 Methods for increasing muscle contractility |
| 11/28/2013 | WO2013177397A1 Multivalent meningococcal conjugates and methods for preparing cojugates |
| 11/28/2013 | WO2013177386A1 Biomarkers for predicting response to tweak receptor (tweakr) agonist therapy |
| 11/28/2013 | WO2013177291A1 Salmonella typhi ty21a expressing yersinia pestis f1-v fusion protein and uses thereof |
| 11/28/2013 | WO2013177264A1 Anti-ccl2 antibodies for treatment of scleroderma |
| 11/28/2013 | WO2013177187A2 Synergistic tumor treatment with extended-pk il-2 and therapeutic agents |
| 11/28/2013 | WO2013177172A2 Herpesvirus compositions and related methods |
| 11/28/2013 | WO2013177157A1 Humanized anti-il-20 antibody and uses thereof |
| 11/28/2013 | WO2013177116A1 Enzymatic modification of anti-aqp4 autoantibody for modulating neuromyelitis optica |
| 11/28/2013 | WO2013177104A2 Treatment for tauopathies |
| 11/28/2013 | WO2013177102A2 Treatment of cancer by manipulating the immune system |
| 11/28/2013 | WO2013177099A1 Method for treating infectious diseases using emissive energy |
| 11/28/2013 | WO2013177098A1 A method for the treatment of neurologic conditions |
| 11/28/2013 | WO2013177096A1 A method for the treatment of cancer |
| 11/28/2013 | WO2013177062A2 Methods for improving safety of blood-brain barrier transport |
| 11/28/2013 | WO2013177055A2 ANTI-Ly6E ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE |
| 11/28/2013 | WO2013177035A2 Humaneered anti-factor b antibody |
| 11/28/2013 | WO2013176754A1 Novel purification of antibodies using hydrophobic interaction chromatography |
| 11/28/2013 | WO2013176516A1 Antibody-drug conjugate prepared by using transglutaminase and use thereof |
| 11/28/2013 | WO2013176503A1 Tau protein mediated neurodegenerative disease therapeutic agent |
| 11/28/2013 | WO2013176469A1 Antibody able to suppress osteoclast differentiation |
| 11/28/2013 | WO2013175427A1 Il-6 binding molecules |
| 11/28/2013 | WO2013175358A1 Stress-regulated prokaryotic expression cassettes |
| 11/28/2013 | WO2013175276A1 Il-6 binding molecules |
| 11/28/2013 | WO2013175258A1 Novel melanoma antigen peptide and uses thereof |
| 11/28/2013 | WO2013175256A1 Novel melanoma antigen peptide and uses thereof |
| 11/28/2013 | WO2013175207A1 Vaccine |
| 11/28/2013 | WO2013175103A1 Method for attenuating a bacterium of the mycobacterium tuberculosis complex for producing a tuberculosis vaccine |
| 11/28/2013 | WO2013174971A1 Secretory immunoglobulin deficiency treatment and prophlaxis |
| 11/28/2013 | WO2013174873A1 Multispecific antibodies |
| 11/28/2013 | WO2013174832A1 Meningococcus serogroup x conjugate |
| 11/28/2013 | WO2013174630A1 Lentiviral vectors containing an mhc class i promoter |
| 11/28/2013 | WO2013174510A1 Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
| 11/28/2013 | WO2013174509A1 Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |
| 11/28/2013 | WO2013174404A1 Combination therapy involving antibodies against claudin 18.2 for treatment of cancer |